Cardiopulmonary exercise testing: utility in research and patient care

Journal of Health and Translational Medicine

Volumn 8, Issue , 2003, Pages 9-17

  Elina, R A ^a   Husain, R ^a   Lang, C C ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cardiopulmonary; Exercise; Oxygen consumption; Physiology; Respiratory medicine

Indexed keywords

EID: 77951442247     PISSN: 18237339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Myers JN. The physiology behind exercise testing. Prim Care 2001; 28 (1) :5-27.
2. Myers F. Special methods: Ventilatory Gas Exchange. In: Exercise and the Heart; Saunders 4th edition 2000; 39-58.
3. American Thoracic Society/American College of Chest Physician. ATS/ACCP Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med 2003; 167:211-277.
4. Mitlehner W. Cardiopulmonary Exercise Testing: Practical guideline. VIASYS info Special Edition CPET 2002; 12-18.
5. Miyamura M, Honda Y. Oxygen intake and cardiac output during treadmill and bicycle exercise. J Appl Physiol 1972; 32:185-188.
6. Bruce RA. Exercise testing of patient with coronary heart disease. Ann Clin Res 1971; 3:323-330.
7. Myers J, Buchanan N, Walsh D et al. Comparison of the ramp vs. standard exercise protocols. J Am Coll Cardiol 1991; 17:1334-42.
8. Myers J, Bellin D. Ramp exercise protocols for clinical and cardiopulmonary exercise testing. Sports Med 2000; 30 (1) :23-29.
9. Cahalin LP, Semigran MJ, Dec. GW. Assessment of oxygen uptake during the 6-minute walk test. Chest 1997; 111:1465-6.
10. Auricchio A, Stellbrink C, Sack S et al. The pacing therapies for congestive heart failure (PATH-CHF) study (abstract) Am J Cardiol 1999; 83:130D-135D.
11. Cazeau S, Laclereq C, Lavergne T, et al for Multisite Stimulation on Cardiomyopathies (MUSTIC) Study Investigators. Effect of multisite biventricular pacing in patients with heart failure and interventricular conduction disturbances. N Engl J Med 2001; 344: 873-880.
12. Vibhuti N, Singh. The role of gas analysis with exercise testing. Prim Care 2001; 28 (1) :159-178.
13. Brubaker, PH. Exercise intolerance in congestive heart failure: A lesson in exercise physiology. J Cardiopulm Rehabil 1997; 17 (4) :217-221.
14. Wilson JR, Mancini DM. Factors contributing to exercise limitation in heart failure. J Am Coll Cardiol 1993; 22:93A-98A.
15. Florea VG, Mareyer VY, Archilov AA, et al. Central and peripheral components of chronic heart failure: Determinants of exercise intolerance. Int J Cardiol 1999; 70 (1) :51-6.
16. Myers S, Graft J, Kunz D, et al. Brain naturetic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002; 40 (4) :718-22.
17. Kinugawa T, Osaki S, Kato M, et al. Effect of angiotensinconverting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild to moderate heart failure. Clin Exp Pharmacol Physiol 2002; 12:1060-1065.
18. Cicoira M, Zanolla L, Rossi A, et al. Long-term, dosedependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 2002; 40 (2) :304-10.
19. Mancini DM, Katz SD, Lang CC, et al. The effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003; 107 (2) :294-9.
20. Steven K, Mohnssen, Idelle M W, et al. Heart or Lung Disease: Determining the primary cause for dyspnoea on exertion. Chest 1998; 113:1705-10.
21. Beckles MA, Spiro SG, Colice GL, et al. American College of Chest Physician. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest (Suppl 1) 2003; 123:105S-114S.
22. Nyman I, Larsson H, Areskog M, et al. The predictive value of silent ischaemia on an exercise test before discharge after an episode of unstable coronary artery disease: RISC study group. Am Heart J 1992; 123:324-331.
23. Szlahcic J, Massio B, Kramer B, et al. Correlations and prognostic implication of exercise capacity in chronic heart failure. Am J Cardiol 1985; 55:1037-1042.
24. Mancini DM, Eisen H, Kussumaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplant in ambulatory patients with heart failure. Circulation 1991; 83:778-786.
25. Osada N, Chaitman BR, Miller LW, et al. Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplant. J Am Coll Cardiol 1998; 31 (3) :577-82.
26. Lipkin DP, Frenneaux M, Stewart R, et al. Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. Br Heart J 1988; 59:572-7.
27. Gosselink ATM, Bulsma EBM, Landsman LJ, et al. Longterm effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation: a two year follow-up. Eur Heart J 1994; 15: 1368-1372.
28. Metra M, Nardi M, Giubbini R, et al. Effect of short and long-term carvedilol administration on rest and exercise haemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994; 24 (7) :1678-87.
29. Grass D, Cazeau S, Ritter P, et al. Long-term results of cardiac resynchronization for heart failure patients:The Insync Clinical Trial. Circulation (Suppl) 1999; 100:510-515.
30. Abraham WT, Fisher MG, Smith AL, et al for Multicenter Insync Randomized Clinical Evaluation (MIRACLE) Investigators and Coordinators. Double blind controlled trial of cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-1853.
31. Inbar O, Dlin R, Rotstein A, et al. Physiological responses to incremental exercise in patients with chronic fatigue syndrome. Med Sci Sports Exerc 2001; 33 (9) :1463-1470.
32. Stringer W. Mechanism of exercise limitation in HIV+ individuals (review). Med Sci Sports Exerc (Suppl) 2000; 32 (7) :S412-421.
33. Sharma S, Elliot PM, Whyte G, et al. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol 2000; 34 (3) :864-70.
34. William MA. Exercise testing in cardiac rehabilitation: Exercise prescription and beyond. Cardiol Clin 2001; 19 (3) :415-31.
35. Keteyian SJ, Levine AB, Brawner, et al. Exercise training in patients with heart failure:A randomized controlled trial. Ann Int Med 1996; 124 (12) :1051-1057.
36. Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure: effects in cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 1996; 25:1239-49.
37. Salman GF, Mosier MC, Beasley B W, et al. Rehabilitation for patients with chronic obstructive pulmonary disease: Meta-analysis of randomized controlled trials. J Gen Int Med 2003;18 (3) :213-221.
38. Wasserman K. Preoperative evaluation of cardiovascular reserve in the elderly. Chest. 1993 Sep; 104 (3) : 663-4.